Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Nash

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Nephron. Clinical Practice|June 26, 2004
A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitorsG V Ramesh Prasad, Michelle M Nash, Philip A McFarlane, et al.
Journal of Nephrology|April 13, 2010
A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across CanadaG V Ramesh Prasad, Michelle M Nash, Tammy Keough-Ryan, et al.
Transplantation|November 14, 2008
A prospective observational study of changes in renal function and cardiovascular risk following living kidney donationG V Ramesh Prasad, Deborah Lipszyc, Michael Huang, et al.
Clinical Transplantation|April 24, 2003
Renal transplant recipient attitudes toward steroid use and steroid withdrawalG V Ramesh Prasad, Michelle M Nash, Philip A McFarlane, et al.
The American Journal of Cardiology|March 10, 2009
Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular riskFarah Bandukwala, Michael Huang, Jeffrey S Zaltzman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 12, 2010
Twenty four-hour ambulatory blood pressure profiles 12 months post living kidney donationG V Ramesh Prasad, Deborah Lipszyc, Sulagna Sarker, et al.
Kidney International|April 17, 2016
Commercial kidney transplantation is an important risk factor in long-term kidney allograft survivalG V Ramesh Prasad, Sailesh Ananth, Sneha Palepu, et al.
BMC Nephrology|March 6, 2022
Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneysAtit A Dharia, Michael Huang, Michelle M Nash, et al.
Clinical Biochemistry|July 31, 2019
Growth differentiation factor 15 is decreased by kidney transplantationPhilip W Connelly, Andrew T Yan, Michelle M Nash, et al.
Journal of Lipids|June 16, 2012
Paraoxonase 1 Phenotype and Mass in South Asian versus Caucasian Renal Transplant RecipientsPhilip W Connelly, Graham F Maguire, Michelle M Nash, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Nephron. Clinical Practice|June 26, 2004
A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitorsG V Ramesh Prasad, Michelle M Nash, Philip A McFarlane, et al.
Journal of Nephrology|April 13, 2010
A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across CanadaG V Ramesh Prasad, Michelle M Nash, Tammy Keough-Ryan, et al.
Transplantation|November 14, 2008
A prospective observational study of changes in renal function and cardiovascular risk following living kidney donationG V Ramesh Prasad, Deborah Lipszyc, Michael Huang, et al.
Clinical Transplantation|April 24, 2003
Renal transplant recipient attitudes toward steroid use and steroid withdrawalG V Ramesh Prasad, Michelle M Nash, Philip A McFarlane, et al.
The American Journal of Cardiology|March 10, 2009
Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular riskFarah Bandukwala, Michael Huang, Jeffrey S Zaltzman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 12, 2010
Twenty four-hour ambulatory blood pressure profiles 12 months post living kidney donationG V Ramesh Prasad, Deborah Lipszyc, Sulagna Sarker, et al.
Kidney International|April 17, 2016
Commercial kidney transplantation is an important risk factor in long-term kidney allograft survivalG V Ramesh Prasad, Sailesh Ananth, Sneha Palepu, et al.
BMC Nephrology|March 6, 2022
Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneysAtit A Dharia, Michael Huang, Michelle M Nash, et al.
Clinical Biochemistry|July 31, 2019
Growth differentiation factor 15 is decreased by kidney transplantationPhilip W Connelly, Andrew T Yan, Michelle M Nash, et al.
Journal of Lipids|June 16, 2012
Paraoxonase 1 Phenotype and Mass in South Asian versus Caucasian Renal Transplant RecipientsPhilip W Connelly, Graham F Maguire, Michelle M Nash, et al.
Pageof 4